C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/12 (2006.01) A61K 31/506 (2006.01) A61P 11/00 (2006.01) A61P 11/06 (2006.01) A61P 19/00 (2006.01) A61P 19/02 (2006.01) C07D 239/34 (2006.01)
Patent
CA 2670166
The invention provides compounds of formula (I): wherein R1 and R2are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.
L'invention porte sur des composés représentés par la formule (I): dans laquelle R1 et R2 sont tels que définis dans la description; sur des procédés pour leur préparation; sur des compositions pharmaceutiques les contenant; un procédé de fabrication des compositions pharmaceutiques; et sur leur utilisation en thérapie. Les composés sont utiles comme inhibiteurs de MMP.
Chapman David
Gabos Balint
Munck Af Rosenschold Magnus
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Hydantoin derivatives used as mmp inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydantoin derivatives used as mmp inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydantoin derivatives used as mmp inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1719927